Highlights
1 patent
About
PeptiCanna has developed a novel patent-granted peptide that improves metabolic parameters for treating obesity and Diabetes type 2 without adverse central nervous system effects.
Identity
| Name | PeptiCanna |
|---|---|
| Slug | pepticanna |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Oi4iIEKDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Dec 2019 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Rosh Haayin |
| HQ address | HaMelacha 22, Rosh Haayin, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
obesitydrug-discoverydiabetespeptidestype-2-diabetespharmaceuticalsstealthmode
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}